Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

China flag China · Delayed Price · Currency is CNY
52.10
-1.42 (-2.65%)
At close: Jun 12, 2026
Market Cap2.02B +35.6%
Revenue (ttm)163.46M -5.6%
Net Income13.28M
EPS0.33
Shares Out 38.78M
PE Ratio156.31
Forward PEn/a
Dividend0.30 (0.58%)
Ex-Dividend DateJun 10, 2026
Volume655,521
Open53.65
Previous Close53.52
Day's Range51.71 - 54.88
52-Week Range37.94 - 63.56
Beta0.32
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About SHA:688193

Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of RNA molecular diagnostic technology and products. It offers products in the areas of reproductive health, bloodborne infections, respiratory infections, enterovirus infections, cancer early detection, and other areas; and AutoSAT, SuperSAT, and ultrasonic homogenizer. The company was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 290
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688193
Full Company Profile

Financial Performance

Financial Statements